This site is intended for healthcare professionals only
LoginRegister
Action taken against 694 manufacturing units since 2022: MinisterGlenmark US arm recalls 15 lakh bottles of ADHD medication in US
Telangana DCA seizes Alka-Shot Oral Solution in BhupalpallyAstraZeneca-Daiichi Sankyo Enhertu recommended for approval in EU for patients with HER2-low or...
Unichem Labs Roha facility gets 3 USFDA observationsUnichem Labs Pithampur API facility gets 4 USFDA observations
Novartis oral Fabhalta gets USFDA nod for adults with C3 glomerulopathyNovartis oral Fabhalta receives positive EMA Committee opinion for adults with C3 glomerulopathy
Sun Pharma Gets CDSCO Panel Nod for Active PMS of Fexuprazan Hydrochloride TabletsSun Pharmaceutical Gets CDSCO Panel Nod To import, market plaque psoriasis drug Tildrakizumab...
JnJ seeks USFDA approval for Tremfya label updateCDSCO Panel Approves Johnson and Johnson's Protocol Amendment proposal for Teclistamab study
No additional tariffs imposed on Indian exports to US in pharma sector: GovtSimplified export norms expected to be introduced in next few weeks: Rajeev Raghuvanshi
Lupin to Conduct BE Study for Synthetic Semaglutide Tablets in 3 StrengthsLupin secures place in Prestigious S&P Global Sustainability Yearbook 2025
Zydus Lifesciences to launch vaccine against new strain of influenza virusZydus Lifesciences to unveil vaccine against new strain of influenza virus
CDSCO Panel Accepts Glenmarks Apremilast Trial Report, Seeks 2-Year PSUR DataGlenmark Pharma USA launches Epinephrine Injection
CDSCO Flags 55 Substandard, 4 Spurious Drugs in June Batch Alert, Full List InsideState Drug Alert: 93 Drug samples fail To Qualify CDSCO Test
Merck to begin Phase 3 trials for investigational once monthly HIV prevention pillMerck to increase workforce at Indian sites by year end
X